Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

針對症狀 Metastatic Androgen Independent Prostate Cancer
臨床試驗編號 NCT00849290
臨床階段 Phase II
臨床試驗位址 58 Study Locations
目前研究進度 This study has been completed.
試驗開始日期 February 19, 2009
試驗開始日期 October 8, 2010
臨床目的 This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)